James E. Scriven

James E. Scriven

Auto-generated profile, based on publicly available information

James E. Scriven

Department of Microbes, Infection & Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham , Birmingham

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
MTMark W. Tenforde
Mark W. Tenforde
JSJames E. Scriven
James E. Scriven
THThomas Stephen Harrison
Thomas Stephen Harrison
JJJoseph N. Jarvis
Joseph N. Jarvis

29 October 2020 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
EOElizabeth Okafor
Elizabeth Okafor
KHKatherine H. Hullsiek
Katherine H. Hullsiek
DWDarlisha A. Williams
Darlisha A. Williams
JSJames E. Scriven
James E. Scriven
JRJoshua Rhein
Joshua Rhein
DBDavid Boulware
David Boulware
Background. Though peripheral blood is a crucial sample to study immunology, it is unclear whether the immune environment in the peripheral vasculature correlates with that at the end-organ site of infection. Using cryptococcal meningitis as a model, we investigated the correlation between serum and cerebrospinal fluid biomarkers over time. Methods. We analyzed the cerebrospinal fluid and serum of 160 subjects presenting with first episode cryptococcal meningitis for soluble cytokines and chemokines measured by Luminex assay. Specimens were collected at meningitis diagnosis, 1-week, and 2-week post cryptococcal diagnosis. We compared paired samples by Spearman’s correlation and the value was set at <0.01. Results. Of the 21 analytes tested at baseline, there was no correlation detected between nearly all analytes. A weak negative correlation was found between serum and cerebrospinal fluid levels of interferon-gamma ( ; ) and interleukin-4 ( ; ). There was no correlation at 1-week post cryptococcal diagnosis. However, at 2-week post cryptococcal diagnosis, there was a weak positive correlation of granulocyte-macrophage colony-stimulating factor levels ( ; ) in serum and cerebrospinal fluid. No cytokine or chemokine showed consistent correlation overtime. Conclusion. Based on our analysis of 21 biomarkers, serum and cerebrospinal fluid immune responses do not correlate. There appears to be a distinct immune environment in terms of soluble biomarkers in the vasculature versus end-organ site of infection. While this is a model of HIV-related cryptococcal meningitis, we postulate that assuming the blood compartment is representative of the immune function at the end-organ site of infection may not be appropriate.

12 January 2026 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
AWAnna L Wilt
Anna L Wilt
DMDavid Meya
David Meya
FCFiona V Cresswell
Fiona V Cresswell
AWAbduljewad Wele
Abduljewad Wele
MKMable Kabahubya
Mable Kabahubya
TBTyler D Bold
Tyler D Bold
Background: Outcomes in tuberculous meningitis (TBM) are closely linked to host inflammation. Anti-inflammatory corticosteroid therapy improves survival in HIV-negative TBM, but not in people with HIV. In people with HIV, TBM is fatal in 40-50% of cases. Therefore, we investigated how mortality is associated with the local immune response in people with HIV-associated TBM. Methods: We measured baseline concentrations of immune signalling mediators in cerebrospinal fluid (CSF) of 149 adults with HIV in Uganda, who presented with definite or probable TBM. Participants received both antimycobacterial and corticosteroid therapy. Results: At baseline, non-survivors had more severe TBM disease and lower blood CD4 T cells than survivors. Mortality at 90 days was strongly associated with CSF hypo-inflammation. CSF interferon gamma (IFN-γ) was most differentially expressed by survivors (2.2 log2-fold change higher, p=.003), and 90-day mortality was lower with increasing concentrations (Tertile-1=50%, Tertile-2=41%, Tertile-3=18%; p=.006). Even among people who successfully mounted a CSF cellular immune response (>5 white cells/μL CSF), those with low CSF IFN-γ had higher risk of death (Hazard Ratio =3.10 (1.44–6.68). Interleukin-13 had a more complex relationship, with lower mortality among people with intermediate CSF interleukin-13 concentrations but higher at the two extremes (Tertile-1=45%, Tertile-2=22%, Tertile-3=40%; p=.017). Of all sub-groups, those with both peripheral CD4 depletion and low CSF IFN-γ had the highest mortality (63%). Conclusions: In adults with HIV-associated TBM receiving dexamethasone, mortality was strongly associated with CSF hypo-inflammation. Although steroids may be appropriate in those with high inflammation, personalized approaches to immunotherapy are likely necessary to improve outcomes.